ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis

ClinicalTrials.gov ID: NCT03148691

Public ClinicalTrials.gov record NCT03148691. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 2:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the Safety and Effectiveness of A-101(Hydrogen Peroxide) Topical Solution in Subjects With Seborrheic Keratosis Lesions on the Trunk, Extremities, and Face

Study identification

NCT ID
NCT03148691
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Aclaris Therapeutics, Inc.
Industry
Enrollment
253 participants

Conditions and interventions

Interventions

  • A-101 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 16, 2017
Primary completion
Feb 27, 2018
Completion
Apr 2, 2018
Last update posted
May 5, 2019

2017 – 2018

United States locations

U.S. sites
9
U.S. states
8
U.S. cities
9
Facility City State ZIP Site status
Center for Dermatology and Dermatologic Surgery Washington D.C. District of Columbia 20037
Baumann Research Institute Miami Florida 33137
MedaPhase, Inc Newnan Georgia 30263
Union Square Laser Dermatology New York New York 10003
Philadelphia Institute - Dermatology Fort Washington Pennsylvania 19034
Perelman Center for Advanced Medicine Philadelphia Pennsylvania 19104
Greenville Dermatology Greenville South Carolina 29607
The Skin Wellness Center, PC Clinical Research Division Knoxville Tennessee 37922
DermResearch Inc Austin Texas 78759

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03148691, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2019 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03148691 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →